In human lung cancers, MAP3K8 is downregulated64, similar to what has been observed in melanoma with BRAF mutation17, possibly to prevent further MEK/ERK activation as a consequence of oncogenic KRAS/BRAF mutations. This evidence concerns the gene MAP3K8 and melanoma.